Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonghua Yusheng Pharmaceutical is a Chinese pharmaceutical company based in Tonghua, Jilin Province, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM). Established in 1999 and restructured in 2001, the company was acquired in 2012 by Changbaishan Pharmaceutical, a subsidiary of the Jilin Shenhua Group. Its flagship product is the DaZhuHongJingTian Injection, a patented TCM derived from Rhodiola and used primarily for treating angina pectoris and other cardiovascular conditions. The company operates modern GMP-certified production lines for various dosage forms, including injections, capsules, and tablets, and is recognized as a high-tech enterprise in the TCM sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonghua Yusheng Pharmaceutical.